We are live on ! Find out more
AC

Athos Capital Portfolio holdings

AUM $324M
1-Year Est. Return 16.62%
This Fund
S&P 500
This Quarter Est. Return
-8.36%
1 Year Est. Return
+16.62%
3 Year Est. Return
+82.15%
5 Year Est. Return
+203.21%
10 Year Est. Return
AUM
$128K
AUM Growth
-$145M
Cap. Flow
-$18.7M
Cap. Flow %
-14,564.08%
Top 10 Hldgs %
50.52%
Holding
100
New
14
Increased
2
Reduced
4
Closed
34

Sector Composition

Rank Sector Weight
1 Healthcare 12.27%
2 Financials 11.94%
3 Technology 5.54%
4 Materials 2.71%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIMO icon
1
CALL
Silicon Motion
SIMO
$8.6B
$10.8K 8.41%
+150,000
New +$9.59M
HHLA.WS
2
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$8.45K 6.59%
806,349
ISEE
3
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$7.87K 6.14%
+200,000
New +$7.06M
TSEM icon
4
CALL
Tower Semiconductor
TSEM
$24.8B
$7.5K 5.86%
+200,000
New +$8.27M
SGEN
5
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
$5.77K 4.51%
+30,000
New +$5.96M
LFACW
6
DELISTED
LF Capital Acquisition Corp. II Warrants
LFACW
$5.34K 4.17%
500,000
HZNP
7
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.14K 4.01%
+50,000
New +$5.28M
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.9K 3.82%
47,600
-12,400
-21% -$1.31M
SGEN
9
DELISTED
Seagen Inc. Common Stock
SGEN
$4.71K 3.68%
24,500
-6,500
-21% -$1.29M
RENE
10
DELISTED
Cartesian Growth Corp II
RENE
$4.27K 3.33%
400,000
ATVI
11
CALL
DELISTED
Activision Blizzard
ATVI
$4.21K 3.29%
50,000
BSAQ
12
DELISTED
Black Spade Acquisition Co
BSAQ
$4.01K 3.13%
388,000
GMED icon
13
Globus Medical
GMED
$10.7B
$3.52K 2.75%
+59,200
New +$3.37M
UNVR
14
DELISTED
Univar Solutions Inc.
UNVR
$3.47K 2.71%
96,900
+1,900
+2% +$67.5K
VMW
15
DELISTED
VMware, Inc
VMW
$3.38K 2.64%
23,500
-6,500
-22% -$843K
RPD icon
16
Rapid7
RPD
$645M
$3.08K 2.4%
+67,900
New +$3.15M
CHEA
17
DELISTED
Chenghe Acquisition Co. Class A Ordinary Share
CHEA
$2.67K 2.09%
250,000
GRND.WS
18
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$2.51K 1.96%
454,651
DEN
19
DELISTED
Denbury Inc.
DEN
$2.18K 1.7%
+25,300
New +$2.29M
BSAQ.WS
20
DELISTED
Black Spade Acquisition Co Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BSAQ.WS
$2.01K 1.57%
193,999
BBIO icon
21
CALL
BridgeBio Pharma
BBIO
$15.7B
$1.72K 1.34%
+100,000
New +$1.5M
SYNH
22
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$1.67K 1.3%
+39,600
New +$1.6M
AJRD
23
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$1.52K 1.19%
27,800
+22,800
+456% +$1.27M
SHUAW
24
DELISTED
SHUAA Partners Acquisition Corp I Warrant
SHUAW
$1.48K 1.15%
137,499
AILEW
25
DELISTED
iLearningEngines, Inc. Warrant
AILEW
$1.46K 1.14%
139,999

Similar funds

Athos Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Athos Capital held 100 positions worth $128K, down 100% from $145M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Athos Capital withdrew a net $18.7M in Q2 2023, closing 34 positions and reducing 4 holdings. Its most notable exit was HH&L Acquisition Co., an estimated $16.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 26% a quarter earlier, followed by Financials and Technology.

Against the trend, Athos Capital opened a new position in Globus Medical worth $3.52K.

  • Athos Capital's largest Q2 2023 buy was Globus Medical: 59,200 shares worth $3.52K.
  • Athos Capital added most to Aerojet Rocketdyne Holdings in Q2 2023, an estimated $1.27M increase.
  • Athos Capital's biggest Q2 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $1.31M.
  • Athos Capital fully exited HH&L Acquisition Co. in Q2 2023, selling an estimated $16.7M.
  • Athos Capital's ten largest holdings make up 51% of its $128K portfolio in Q2 2023.
  • Athos Capital opened 14 new positions and closed 34 in Q2 2023.
  • Athos Capital's portfolio value fell 100% quarter-over-quarter to $128K.

Based on Athos Capital's 13F filing for Q2 2023, filed 14 Aug 2023.